ArticleOncotarget2017

Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate.

Lorenzo Depau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.